Omaha, NE – Streck’s new line of CE-marked antibiotic resistance monitoring and detection (ARM-D) kits are now available. The Streck ARM-D® Kits, ampC and ?-Lactamase are multiplex real-time PCR reagents for the detection of more than 450 ? lactamase gene targets. The kits are For Export Only. Not for sale in the U.S.
The Streck ARM-D Kits detect the presence of antibiotic resistance genes in bacteria that cause difficult-to-treat infections and that have the ability to spread quickly, especially in a hospital environment. The Streck ARM-D Kits can detect the presence of resistance mechanisms of current clinical importance, such as carbapenemases and extended spectrum ?-Lactamases (ESBLs) and some emerging threats, such as the AmpC cephalosporinases. Current phenotypic methods may mischaracterize or fail to detect genetic mechanisms of antibiotic resistance. The Streck ARM-D Kits are a genotypic detection method that can be used to identify the most prevalent types of ?-lactamase-based antibiotic resistance.
Streck developed the ARM-D Kits to provide laboratories with a comprehensive, cost-effective molecular method to detect the most clinically-important ?-lactamases known to cause therapeutic failure. These kits can be used to complement standard susceptibility tests, improve surveillance and epidemiologic tracking, and also foodborne pathogen and waste water testing.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.